MedPath
FDA Approval

Pranactin-Citric

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
August 24, 2009
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Urea C-13(75 mg in 3000 mg)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Otsuka America Pharmaceutical

008314390

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Pranactin-Citric

Product Details

NDC Product Code
59148-023
Application Number
NDA020586
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
September 18, 2009
Urea C-13Active
Code: W6KX9E6D8XClass: ACTIMQuantity: 75 mg in 3000 mg
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSLClass: IACTQuantity: 2000 mg in 3000 mg
MANNITOLInactive
Code: 3OWL53L36AClass: IACTQuantity: 775 mg in 3000 mg
ASPARTAMEInactive
Code: Z0H242BBR1Class: IACTQuantity: 150 mg in 3000 mg
© Copyright 2025. All Rights Reserved by MedPath